-
Encuesta de Evaluación del Desempeño Docente 16 Jan 202316/01/23 at 13:012023-01-16 13:01:16
-
Nota Final 4 Jan 202304/01/23 at 13:082023-01-04 13:08:04
Ariel Castro L.
-
Re (11): Notas 3 Jan 202303/01/23 at 13:312023-01-03 13:31:03
Camila Quirland L.
-
Trabajo Economía de la salud 3 Jan 202303/01/23 at 13:302023-01-03 13:30:03
Camila Quirland L.
-
Re (10): Notas 2 Jan 202302/01/23 at 17:482023-01-02 17:48:02
Carlos Yáñez
-
Trabajo de Marketing 30 Dec 202230/12/22 at 13:232022-12-30 13:23:30
Tomás Arévalo M.
-
Re (9): Notas 28 Dec 202228/12/22 at 12:462022-12-28 12:46:28
Miranda Kossen V.
-
Re (8): Notas 28 Dec 202228/12/22 at 12:372022-12-28 12:37:28
Lenni Appoleon Á.
-
Re (7): Notas 28 Dec 202228/12/22 at 12:152022-12-28 12:15:28
Camila Quirland L.
-
Re (6): Notas 27 Dec 202227/12/22 at 10:242022-12-27 10:24:27
Fernanda Pastén
-
Re (5): Notas 26 Dec 202226/12/22 at 15:532022-12-26 15:53:26
Diego Cam
-
Re (4): Notas 26 Dec 202226/12/22 at 15:522022-12-26 15:52:26
Michelle Marambio
-
Re (3): Notas 26 Dec 202226/12/22 at 15:402022-12-26 15:40:26
Nicol Valdivia
-
Re (2): Notas 26 Dec 202226/12/22 at 15:392022-12-26 15:39:26
Sofía Urrea Córdova
-
Re (1): Notas 26 Dec 202226/12/22 at 15:382022-12-26 15:38:26
Javiera Zapata
-
Notas 26 Dec 202226/12/22 at 15:242022-12-26 15:24:26
Francisca Meneses Guerra
-
Dasatinib bioequivalente final.pdf 22 Dec 202222/12/22 at 23:582022-12-22 23:58:22
Joselin Sandoval G.
-
Plan marketing Ceritinib DEFINITIVO 22 Dec 202222/12/22 at 23:502022-12-22 23:50:22
Luis Valenzuela V.
-
PLAN DE MARKETING LANZAMIENTO DE TRASTUZUMAB BIOSIMILAR.pdf 22 Dec 202222/12/22 at 23:182022-12-22 23:18:22
Estefanía Mora
-
Plan de Marketing - Trastuzumab .docx 22 Dec 202222/12/22 at 23:102022-12-22 23:10:22
Iván Acuña S.
-
PEMBROLIZUMAB .docx 22 Dec 202222/12/22 at 22:342022-12-22 22:34:22
Javier Gutiérrez
-
Plan de marketing Pembrolizumab.pdf 22 Dec 202222/12/22 at 22:232022-12-22 22:23:22
Vicente Arancibia Aguilera
-
Plan de Marketing - Ceritinib.pdf 22 Dec 202222/12/22 at 22:032022-12-22 22:03:22
Macarena Pinto R.
-
Plan de Marketing Trastuzumab biosimilar.pdf 22 Dec 202222/12/22 at 19:562022-12-22 19:56:22
Yasna González R.
-
Caso_Ceritinib (1).docx 22 Dec 202222/12/22 at 19:422022-12-22 19:42:22
Claudia González M.